MedPath

Multimodal Approach to Preventing Suicide in Schools (MAPSS): A regionally-based trial of safeTALK and Reframe IT among secondary school students (Reframe IT component)

Not Applicable
Conditions
Depression
Suicide
Mental Health - Depression
Mental Health - Suicide
Registration Number
ACTRN12621000279820
Lead Sponsor
niversity of Melbourne
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
268
Inclusion Criteria

Current year 10 or 11 student at a secondary school in North West Melbourne who has consented to participate in the broader MAPSS trial and reports suicidal ideation within the past four weeks.

Past-four-week suicidal ideation past four-week suicidal ideation will be indicated by either a score of 21 or higher on the Suicidal Ideation Attributes Scale (SIDAS), or a score of 1-20 confirmed by a screening interview with a researcher.

Exclusion Criteria

1. Intellectual disability;
2. Inability to converse in, or read English.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Suicidal ideation, assessed using the Suicidal Ideation Attributes Scale (SIDAS)[Twelve weeks (Time 3) and 24 weeks (Time 4) post-baseline, as compared to two weeks post-baseline (Time 2).<br>]
Secondary Outcome Measures
NameTimeMethod
Symptoms of depression, assessed using the Patient Health Questionnaire – 9 item (PHQ-9)[Twelve weeks (Time 3) and 24 weeks (Time 4) post-baseline, as compared to two weeks post-baseline (Time 2).<br>];Hopelessness, assessed using the Hopelessness Scale for Children (HSC)[Twelve weeks (Time 3) and 24 weeks (Time 4) post-baseline, as compared to two weeks post-baseline (Time 2).<br>];Problem-solving, assessed using the Negative Problem Orientation Questionnaire (NPOQ)[Twelve weeks (Time 3) and 24 weeks (Time 4) post-baseline, as compared to two weeks post-baseline (Time 2).];Health-service use, assessed using the Resource Use Questionnaire (RUQ)[Twelve weeks (Time 3) and 24 weeks (Time 4) post-baseline, as compared to two weeks post-baseline (Time 2).<br>];Acceptability of Reframe IT, assessed using a purpose-designed questionnaire[Twelve weeks post-baseline (Time 3)]
© Copyright 2025. All Rights Reserved by MedPath